These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases? Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992 [TBL] [Abstract][Full Text] [Related]
6. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases. Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727 [TBL] [Abstract][Full Text] [Related]
7. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan. Goshen E; Davidson T; Zwas ST; Aderka D Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400 [TBL] [Abstract][Full Text] [Related]
8. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495 [TBL] [Abstract][Full Text] [Related]
9. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470 [TBL] [Abstract][Full Text] [Related]
10. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. Sarikaya I; Povoski SP; Al-Saif OH; Kocak E; Bloomston M; Marsh S; Cao Z; Murrey DA; Zhang J; Hall NC; Knopp MV; Martin EW World J Surg Oncol; 2007 Jul; 5():80. PubMed ID: 17634125 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Truant S; Huglo D; Hebbar M; Ernst O; Steinling M; Pruvot FR Br J Surg; 2005 Mar; 92(3):362-9. PubMed ID: 15672427 [TBL] [Abstract][Full Text] [Related]
12. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421 [TBL] [Abstract][Full Text] [Related]
13. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease. Denecke T; Steffen I; Hildebrandt B; Rühl R; Streitparth F; Lehmkuhl L; Langrehr J; Ricke J; Amthauer H; Hänninen EL Acta Radiol; 2007 Oct; 48(8):821-30. PubMed ID: 17924212 [TBL] [Abstract][Full Text] [Related]
14. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565 [TBL] [Abstract][Full Text] [Related]
15. Role of FDG-PET in surgical management of patients with colorectal liver metastases. Teague BD; Morrison CP; Court FG; Chin VT; Costello SP; Kirkwood ID; Maddern GJ ANZ J Surg; 2004 Aug; 74(8):646-52. PubMed ID: 15315564 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Niekel MC; Bipat S; Stoker J Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538 [TBL] [Abstract][Full Text] [Related]
17. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer]. Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291 [TBL] [Abstract][Full Text] [Related]
18. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer. Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996 [TBL] [Abstract][Full Text] [Related]
19. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324 [TBL] [Abstract][Full Text] [Related]
20. Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Wiering B; Vogel WV; Ruers TJ; Oyen WJ Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]